Reset filter
Palavras-chave
Primary Malignant Brain Neoplasms ×
Mostrar mais Palavras-chave
Índice
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Modelos de dados selecionados

Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.

135 Resultados da pesquisa.
Relevância Avaliação Novos primeiro Antigos primeiro

Recurring cancer children (ADVL0212 NCT00053963) - Reporting Period Worksheet cancer (NCT00053963)

- 22/03/2015 - 1 Formulário, 5 Grupos de itens, 58 Elementos de dados, 1 Idioma
Grupos de itens: Header, Patient characteristics, Concomitant Medication, Patient status, Adverse event
ADVL0212: Reporting Period Worksheet FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1EC15B1-1989-311F-E034-0003BA12F5E7

Eligibility Brain Cancer NCT01065805

- 20/08/2019 - 1 Formulário, 2 Grupos de itens, 13 Elementos de dados, 1 Idioma
Grupos de itens: Inclusion Criteria, Exclusion Criteria
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01065805

dbGaP phs000725 Rare Cancer Tumors Project - pht003882.v2.p1

- 06/01/2023 - 9 Formulários, 1 Grupo de itens, 5 Elementos de dados, 1 Idioma
Grupo de itens: pht003882
Principal Investigator: David A. Wheeler, PhD, Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA MeSH: Neoplasms,Brain Neoplasms,Germinoma,Neoplasms, Germ Cell and Embryonal,Endodermal Sinus Tumor,Teratoma,Carcinoma, Embryonal,Choriocarcinoma,Polycythemia Vera,Craniopharyngioma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000725 A large proportion of common cancers affecting patients around the world have been selected for comprehensive cancer genome studies. Further efforts will be needed to tackle the remaining tumor types, including the rare forms of cancers. Although rare, these cancers tend to be more aggressive and fast growing with an early recurrence following initial chemotherapy and poor prognosis. Besides, patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer. While sample collection is a major challenge, the integrated genomic analyses would identify novel causative genes in these rare cancers, shed new light on the biology of the rare cancers, as well as guide novel targeted cancer therapies. Through efficient collaboration, the Human Genome Sequencing Center (HGSC) at Baylor College of Medicine (BCM) has collected/is expected to collect 20 different types of rare cancers, 15-30 cases each. Whole-exome sequencing and high-resolution SNP array analysis were/will be performed for all cases and whole-genome sequencing was designed for a selected subset of the cases. *The Rare Cancer Tumors Cohort is utilized in the following dbGaP sub-studies.* To view genotypes, other molecular data, and derived variables collected in this sub-study, please click on the following sub-study below or in the "Sub-studies" section of this top-level study page phs000725 Rare Cancer Tumors Cohort.- phs000754 Intracranial Germ Cell Tumors - phs000861 Craniopharyngioma Tumors - phs000859 Sezary Syndrome Genomic Analysis

pht003885.v2.p1

1 Grupo de itens 3 Elementos de dados

pht003886.v2.p1

1 Grupo de itens 5 Elementos de dados

pht004475.v2.p1

1 Grupo de itens 4 Elementos de dados

pht004476.v2.p1

1 Grupo de itens 6 Elementos de dados

pht004585.v2.p1

1 Grupo de itens 5 Elementos de dados

Eligibility

1 Grupo de itens 1 Elemento de dados

HIV Cancer Sunitinib NCT00890747 AMC-061 - Response Evaluation Form (R61)

- 24/06/2017 - 1 Formulário, 7 Grupos de itens, 35 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, Complete Response, Morphologic Complete Remission, Complete Response, Unconfirmed, Complete Response with Incomplete Bone Marrow Recovery, PR, Progressive Disease
AMC-061 Response Evaluation Form (R61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

Sunitinib in HIV with Cancer NCT00890747 AMC-061 - HIV Viral Load Form (F40)

- 20/06/2017 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, HIV Viral Load
AMC-061 HIV Viral Load Form (F40) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

Sunitinib in HIV with Cancer NCT00890747 AMC-061 - Off Study Summary Form (F50)

- 20/06/2017 - 1 Formulário, 1 Grupo de itens, 4 Elementos de dados, 1 Idioma
Grupo de itens: Off-Study Summary
AMC-061 Off Study Summary Form (F50) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

HIV Cancer Sunitinib NCT00890747 AMC-061 - Missed Visit Form (F35)

- 12/06/2017 - 1 Formulário, 2 Grupos de itens, 6 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, Missed Visit Information
AMC-061 Missed Visit Form (F35) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

HIV Cancer Sunitinib NCT00890747 AMC-061 - Pharmacokinetics Form (P61)

- 12/06/2017 - 1 Formulário, 2 Grupos de itens, 5 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, Pharmacodynamics
AMC-061 Pharmacokinetics Form (P61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

HIV Cancer Sunitinib NCT00890747 AMC-061 - Protocol Deviation Form (DEV)

- 12/06/2017 - 1 Formulário, 2 Grupos de itens, 10 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, Protocol Deviation
AMC-061 Protocol Deviation Form (DEV) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

HIV with Cancer Baseline AMC-061 NCT00890747 - Baseline Evaluation Form HIV with Cancer NCT00890747

- 20/05/2015 - 1 Formulário, 4 Grupos de itens, 19 Elementos de dados, 1 Idioma
Grupos de itens: Header Module, SOLID TUMOR/LYMPHOMA ASSESSMENT, KAPOSI'S SARCOMA ASSESSMENT, HEMATOLOGIC MALIGNANCY ASSESSMENT
AMC-061 Baseline Evaluation Form (B61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy NCT00890747 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=715BD918-9168-2975-E040-BB89AD434610

Toxicity - Brain Cancer - Adverse Event Form - 2263172v3.0 - Brain Cancer - Adverse Event Form

- 09/01/2015 - 1 Formulário, 4 Grupos de itens, 23 Elementos de dados, 1 Idioma
Grupos de itens: CRF Header, Brain: Form Administration, Brain: Adverse Events, Comments
Brain Cancer - Adverse Event Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE93FBC6-0592-249A-E034-0003BA12F5E7

Treatment - Brain Cancer - Definitive Surgery Form - 2286489v3.0 - Brain Cancer - Definitive Surgery Form

- 09/01/2015 - 1 Formulário, 5 Grupos de itens, 20 Elementos de dados, 1 Idioma
Grupos de itens: CRF Header, Brain: Form Administration, Brain: Surgical Treatment for Primary Site, Brain: Most Recent Surgery, Comments
Brain Cancer - Definitive Surgery Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE9506AA-7EEF-2525-E034-0003BA12F5E7

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial